Important Information
If you are interested in applying for this study, please:
- Read the study description and study information document.
- Review the Visit Planner dates in your location and confirm that you are available for the stated dates.
- If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
- If you have already registered with us, answer the pre-screening questions listed below and submit your interest.
We will then contact you to check your suitability.
Study Information
New Zealand Clinical Research is trialling an experimental drug to observe the safety, tolerability and how the drug is broken down and eliminated from the body. If this study is successful, this experimental drug may potentially be used for the treatment of HIV type 1 (human immunodeficiency virus). HIV is a virus that attacks the immune system, the body’s defence, against diseases. Chronic infection of HIV can lead to an impaired immune system which leads to Acquired Immunodeficiency Syndrome (AIDS).
Typically, HIV-1 infection is treated with a combination of oral ARV (antiretroviral) drugs which delay disease progression. These drugs generally need to be taken every day and require strict adherence to be optimally effective. This drug is being tested as it is hoped that it can provide an alternative treatment, being administered on a less frequent basis.
This study will test an experimental drug, which is being developed as a potential antiviral treatment for HIV-1. The drug has been approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) in a different formulation than what is being investigated in this study. Thus, the drug used in this study is an investigational product because it has not been approved by the New Zealand MedSafe or other drug regulatory authorities.
Requirements
Healthy Males and Females
- Be aged 18+
- Non-smokers, or have stopped more than 6 weeks ago
- Not currently taking any regular prescription medications for your health (e.g., anti-depressants)
What is Involved?
Study Visits: 15-night stay + 17 Clinic visits + 4 follow-up phone calls
Reimbursement: Up to $14,000 before tax
Important Documents
Important documents to download and read
Pre-screening Form
Indigo Trial
Pre screening for Indigo